$35 Million

Aptinyx

Follow-on Offering

Lead Left Bookrunner, January 2020

Aptinyx
Aptinyx Inc. is a clinical stage biopharmaceutical company. The Company focused on discovering and developing therapies for disorders of the brain and nervous system.